Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism neuraminidase inhibitors(Influenza A Neuraminidase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H34N2O5S |
InChIKeyAEQWUSSTTYLLFR-QQKQFIJSSA-N |
CAS Registry2685786-29-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza, Human | Preclinical | China | 08 Aug 2022 |